MyFinsight
Home
Blog
About
Accounts payable and
accrued liabilities
$1,747,323
(11.06%↑ Y/Y)
Changes in the fair value
of derivative...
-$955,447
(-64588.35%↓ Y/Y)
Amortization of debt discount
$345,144
(496.47%↑ Y/Y)
Depreciation and
amortization expense
$90,810
(-14.85%↓ Y/Y)
Cash provided (used)
by operating...
$331,974
(161.36%↑ Y/Y)
Canceled cashflow
$2,806,750
Net increase in cash
$261,856
(-41.61%↓ Y/Y)
Canceled cashflow
$70,118
Net loss
-$2,339,651
(-13.26%↓ Y/Y)
Prepaid expenses
$198,709
(88.92%↑ Y/Y)
Inventory
$182,967
(91.44%↑ Y/Y)
Accounts receivable
$75,423
(436.02%↑ Y/Y)
Other asset
$10,000
Cash used by
investing activities
-$43,499
(60.66%↑ Y/Y)
Cash provided by
financing activities
-$26,619
(-102.42%↓ Y/Y)
Purchase of property and
equipment
$43,499
(-60.66%↓ Y/Y)
Proceeds from issuance of
debt
-$26,619
(-102.42%↓ Y/Y)
Back
Back
Cash Flow
Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)
source: myfinsight.com